[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619334":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":14,"responsibleParty":34,"collaborators":7,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":53,"overallStatus":17,"whyStopped":7,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"University Hospital, Strasbourg, France","OTHER",null,[9],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Philippe Schultz, MD, PhD","CONTACT","33 3 88 12 76 36","philippe.schultz@chru-strasbourg.fr",[15],{"facility":16,"status":17,"city":18,"state":7,"zip":19,"country":20,"countryCode":21,"cosmosGeoPoint":22,"geoPoint":27,"contacts":28},"Service d'ORL et de Chirurgie Cervico-faciale - CHU de Strasbourg - France","RECRUITING","Strasbourg","67091","France","FR",{"type":23,"coordinates":24},"Point",[25,26],7.74553,48.58392,{"lat":26,"lon":25},[29,30,32],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"name":10,"role":31,"phone":7,"phoneExt":7,"email":7},"PRINCIPAL_INVESTIGATOR",{"name":33,"role":31,"phone":7,"phoneExt":7,"email":7},"Thibault DEDIEU, MD",{"type":35,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100619334","dual-energy-ct-vs-mri-in-the-evaluation-of-squamous-cell-carcinomas-of-the-oral-cavity-and-oropharynx-100619334",false,"NCT07343271","Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx","DECT-CEco","Inclusion Criteria:\n\n* Adult patient (≥18 years)\n* presenting with oral or oropharyngeal squamous cell carcinoma proven by histopathological analysis of a biopsy\n* having undergone a clinical examination with nasofibroscopy by an ENT surgeon specializing in cancer surgery\n* a contrast-enhanced cervicofacial MRI\n* and a contrast-enhanced cervicofacial DECT with BOLT maneuver.\n\nExclusion Criteria:\n\n* A lesion other than oral or oropharyngeal squamous cell carcinoma\n* A labial location\n* A contraindication to performing one or both of the imaging examinations.","ALL","18 Years",{"count":46,"type":47},30,"ESTIMATED","OBSERVATIONAL","The diagnostic and pre-therapeutic assessment of squamous cell carcinomas requires a neck and chest CT scan and a neck and facial MRI, which is the most effective examination, to establish the TNM stage of the tumor. However, obtaining this complete assessment can delay treatment. Confirmation of the non-inferiority of 40keV dual-energy CT in BOLT compared to MRI would spare the patient an additional MRI examination, speed up the pre-treatment assessment, reduce the loss of opportunity due to delayed treatment, and free up MRI imaging slots, which are still insufficient in the region.",[51,52],"Oral Squamous Cell Carcinoma","Oropharyngeal Squamous Cell Carcinoma",[51,52,54],"TNM stage of the tumor","2026-01-06",{"date":57,"type":58},"2026-01-15","ACTUAL",{"date":60,"type":58},"2025-07-11",{"date":62,"type":47},"2026-07-11",{"name":5,"class":6},1]